Neuralink's CEO said this type of device will eventually enable people to interact with large language models (LLMs) without using a keyboard or voice input.
AbbVie has filed for approval of a regimen based on its Venclexta therapy for previously untreated patients with chronic lymphocytic leukaemia (CLL), in combination with an AstraZeneca drug. The ...
Microsoft has announced that an upcoming update to Windows Notepad will enable support for generating and summarizing text ...